Literature DB >> 25596714

Curcumin inhibits LPA-induced invasion by attenuating RhoA/ROCK/MMPs pathway in MCF7 breast cancer cells.

Kai Sun1, Xiaoyi Duan2, Hui Cai1,3, Xiaohong Liu4, Ya Yang1, Min Li1, Xiaoyun Zhang5, Jiansheng Wang6.   

Abstract

Breast cancer generally shows poor prognosis because of its invasion and metastasis. Lysophosphatidic acid (LPA) induces and aggravates cancer invasion and metastasis by activating its downstream signal pathways. RhoA/ROCK/MMP signaling was found one of the LPA-induced pathways, which may be involved in invasion of breast cancer. Furthermore, we investigated whether this pathway was involved in curcumin's effect against LPA-induced invasion. LPA incubation was used to enhance invasion of MCF-7 breast cancer cells. RhoA expression was knocked-down by siRNA technique. MTT assay was used to evaluate the proliferation. Transwell assay was utilized to investigate the invasion ability of MCF-7 cells. Real-time PCR and Western blotting were used to assess the expressions of RhoA, ROCK1, ROCK2, MMP2 and MMP9 at both translational and transcriptional levels. The RhoA and ROCK activities were also evaluated. LPA incubation significantly boosted invasion rate of MCF-7. RhoA silencing by siRNA dramatically inhibited LPA-enhanced invasion. Concurrently, RhoA and ROCK activities and expression levels of RhoA, ROCK1, ROCK2, MMP2 and MMP9 were down-regulated by RhoA siRNA transfection. In order to avoid influence of cytotoxicity of curcumin, concentrations below 45 μmol/L were selected to further investigate the mechanism of curcumin's anti-invasion effect. Invasion of LPA-incubated MCF-7 cells was impaired by curcumin in a concentration-dependent manner. Concurrently, RhoA and ROCK activities and expression levels of RhoA, ROCK1, ROCK2, MMP2 and MMP9 were down-regulated by curcumin in a concentration-dependent manner. In conclusion, RhoA/ROCK/MMPs pathway activation is involved in LPA-induced invasion in MCF-7 cells; curcumin inhibited LPA-induced invasion in MCF-7 cells by attenuating RhoA/ROCK/MMPs pathway.

Entities:  

Keywords:  Breast cancer; Curcumin; Invasion; Lysophosphatidic acid

Mesh:

Substances:

Year:  2015        PMID: 25596714     DOI: 10.1007/s10238-015-0336-7

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  41 in total

1.  Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model.

Authors:  Odete Mendes; Hun-Taek Kim; George Stoica
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 2.  Autotaxin and LPA receptor signaling in cancer.

Authors:  Anna J S Houben; Wouter H Moolenaar
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

3.  Regulation of MT1-MMP and MMP-2 by leptin in cardiac fibroblasts involves Rho/ROCK-dependent actin cytoskeletal reorganization and leads to enhanced cell migration.

Authors:  Kristin Schram; Riya Ganguly; Eun Kyung No; Xiangping Fang; Farah S L Thong; Gary Sweeney
Journal:  Endocrinology       Date:  2011-03-08       Impact factor: 4.736

4.  LPA(1) -induced migration requires nonmuscle myosin II light chain phosphorylation in breast cancer cells.

Authors:  Jong Hyun Kim; Robert S Adelstein
Journal:  J Cell Physiol       Date:  2011-11       Impact factor: 6.384

5.  The RhoA pathway mediates MMP-2 and MMP-9-independent invasive behavior in a triple-negative breast cancer cell line.

Authors:  Katerina D Fagan-Solis; Sallie Smith Schneider; Brian T Pentecost; Brook A Bentley; Christopher N Otis; John F Gierthy; Kathleen F Arcaro
Journal:  J Cell Biochem       Date:  2013-06       Impact factor: 4.429

Review 6.  Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: a focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays.

Authors:  Semjon Willier; Elke Butt; Thomas G P Grunewald
Journal:  Biol Cell       Date:  2013-06-03       Impact factor: 4.458

7.  LPA: a novel lipid mediator with diverse biological actions.

Authors:  W H Moolenaar
Journal:  Trends Cell Biol       Date:  1994-06       Impact factor: 20.808

8.  Curcumin modulates miR-19/PTEN/AKT/p53 axis to suppress bisphenol A-induced MCF-7 breast cancer cell proliferation.

Authors:  Xiaoting Li; Wei Xie; Chunfeng Xie; Cong Huang; Jianyun Zhu; Zhaofeng Liang; Feifei Deng; Mingming Zhu; Weiwei Zhu; Rui Wu; Jieshu Wu; Shanshan Geng; Caiyun Zhong
Journal:  Phytother Res       Date:  2014-05-15       Impact factor: 5.878

9.  Lysophosphatidic acid induces MDA-MB-231 breast cancer cells migration through activation of PI3K/PAK1/ERK signaling.

Authors:  Jun Du; Chongqi Sun; Zhenzhen Hu; Yu Yang; Yichao Zhu; Datong Zheng; Luo Gu; Xiang Lu
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

Review 10.  Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment.

Authors:  Purusotam Basnet; Natasa Skalko-Basnet
Journal:  Molecules       Date:  2011-06-03       Impact factor: 4.411

View more
  23 in total

Review 1.  Molecular mechanisms of curcumin and its semisynthetic analogues in prostate cancer prevention and treatment.

Authors:  Brian C Jordan; Charlotta D Mock; Ramasamy Thilagavathi; Chelliah Selvam
Journal:  Life Sci       Date:  2016-03-24       Impact factor: 5.037

Review 2.  Role of autotaxin in cancer stem cells.

Authors:  Dongjun Lee; Dong-Soo Suh; Sue Chin Lee; Gabor J Tigyi; Jae Ho Kim
Journal:  Cancer Metastasis Rev       Date:  2018-09       Impact factor: 9.264

3.  Dietary patterns in association with the expression of pro-metastatic genes in primary breast cancer.

Authors:  Mitra Foroutan-Ghaznavi; Seyed-Mohammad Mazloomi; Vahid Montazeri; Saeed Pirouzpanah
Journal:  Eur J Nutr       Date:  2022-04-28       Impact factor: 4.865

Review 4.  Modulation of the tumor microenvironment by natural agents: implications for cancer prevention and therapy.

Authors:  Haseeb Zubair; Mohammad Aslam Khan; Shashi Anand; Sanjeev Kumar Srivastava; Seema Singh; Ajay Pratap Singh
Journal:  Semin Cancer Biol       Date:  2020-05-26       Impact factor: 15.707

5.  Roles of Ras Homolog A in Invasive Ductal Breast Carcinoma.

Authors:  Eriko Murakami; Yoko Nakanishi; Yukari Hirotani; Sumie Ohni; Xiaoyan Tang; Shinobu Masuda; Katsuhisa Enomoto; Kenichi Sakurai; Sadao Amano; Tsutomu Yamada; Norimichi Nemoto
Journal:  Acta Histochem Cytochem       Date:  2016-10-29       Impact factor: 1.938

6.  Prognostic value and functional role of ROCK2 in pediatric Ewing sarcoma.

Authors:  Gabriela Maciel Vieira; Gabriela Molinari Roberto; Régia Caroline Lira; Edgard Eduard Engel; Luiz Gonzaga Tone; María Sol Brassesco
Journal:  Oncol Lett       Date:  2017-12-08       Impact factor: 2.967

7.  The effects of turmeric (curcumin) on tumor suppressor protein (p53) and estrogen receptor (ERα) in breast cancer cells.

Authors:  Kelly Hallman; Katie Aleck; Brigitte Dwyer; Victoria Lloyd; Meghan Quigley; Nada Sitto; Amy E Siebert; Sumi Dinda
Journal:  Breast Cancer (Dove Med Press)       Date:  2017-03-10

8.  Eicosopentaneoic Acid and Other Free Fatty Acid Receptor Agonists Inhibit Lysophosphatidic Acid- and Epidermal Growth Factor-Induced Proliferation of Human Breast Cancer Cells.

Authors:  Mandi M Hopkins; Zhihong Zhang; Ze Liu; Kathryn E Meier
Journal:  J Clin Med       Date:  2016-01-26       Impact factor: 4.241

Review 9.  Curcumin: the spicy modulator of breast carcinogenesis.

Authors:  Urmila Banik; Subramani Parasuraman; Arun Kumar Adhikary; Nor Hayati Othman
Journal:  J Exp Clin Cancer Res       Date:  2017-07-19

10.  The IKK/NF-κB signaling pathway requires Morgana to drive breast cancer metastasis.

Authors:  Federica Fusella; Laura Seclì; Elena Busso; Anna Krepelova; Enrico Moiso; Stefania Rocca; Laura Conti; Laura Annaratone; Cristina Rubinetto; Maurizia Mello-Grand; Vijay Singh; Giovanna Chiorino; Lorenzo Silengo; Fiorella Altruda; Emilia Turco; Alessandro Morotti; Salvatore Oliviero; Isabella Castellano; Federica Cavallo; Paolo Provero; Guido Tarone; Mara Brancaccio
Journal:  Nat Commun       Date:  2017-11-21       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.